<?xml version="1.0" ?>
<document id="e38a8320180661475487156ee68de426868e6c45">
  <chunk id="e38a8320180661475487156ee68de426868e6c45.c0" text="cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!">
    <entity charOffset="43-49" id="e38a8320180661475487156ee68de426868e6c45.c0.e0" ontology_id="DOID_162" text="Cancer" type="disease"/>
  </chunk>
  <chunk id="e38a8320180661475487156ee68de426868e6c45.c1" text="The acidic vesicles of the endolysosomal (EL) system are emerging as an intracellular Ca 2+ store implicated in the regulation of multiple cellular functions. The EL Ca 2+ store releases Ca 2+ through a variety of Ca 2+ -permeable channels, including Transient Receptor Potential (TRP) Mucolipin 1-3 (TRPML1-3) and two-pore channels 1-2 (TPC1-2), whereas EL Ca 2+ refilling is sustained by the proton gradient across the EL membrane and/or by the endoplasmic reticulum (ER). EL Ca 2+ signals may be either spatially restricted to control vesicle trafficking, autophagy and membrane repair or may be amplified into a global Ca 2+ signal through the Ca 2+ -dependent recruitment of ER-embedded channels. Emerging evidence suggested that nicotinic acid adenine dinucleotide phosphate (NAADP)-gated TPCs sustain multiple cancer hallmarks, such as migration, invasiveness and angiogenesis. Herein, we first survey the EL Ca 2+ refilling and release mechanisms and then focus on the oncogenic role of EL Ca 2+ signaling. While the evidence in favor of TRPML1 involvement in neoplastic transformation is yet to be clearly provided, TPCs are emerging as an alternative target for anticancer therapies.">
    <entity charOffset="281-284" id="e38a8320180661475487156ee68de426868e6c45.c1.e0" ontology_id="CHEBI_16828" text="TRP" type="chemical"/>
    <entity charOffset="281-284" id="e38a8320180661475487156ee68de426868e6c45.c1.e1" ontology_id="CHEBI_27897" text="TRP" type="chemical"/>
    <entity charOffset="394-400" id="e38a8320180661475487156ee68de426868e6c45.c1.e2" ontology_id="CHEBI_24636" text="proton" type="chemical"/>
    <entity charOffset="735-749" id="e38a8320180661475487156ee68de426868e6c45.c1.e3" ontology_id="CHEBI_15940" text="nicotinic acid" type="chemical"/>
    <entity charOffset="745-749" id="e38a8320180661475487156ee68de426868e6c45.c1.e4" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="750-757" id="e38a8320180661475487156ee68de426868e6c45.c1.e5" ontology_id="CHEBI_16708" text="adenine" type="chemical"/>
    <entity charOffset="758-770" id="e38a8320180661475487156ee68de426868e6c45.c1.e6" ontology_id="CHEBI_47885" text="dinucleotide" type="chemical"/>
    <entity charOffset="771-780" id="e38a8320180661475487156ee68de426868e6c45.c1.e7" ontology_id="CHEBI_18367" text="phosphate" type="chemical"/>
    <entity charOffset="817-823" id="e38a8320180661475487156ee68de426868e6c45.c1.e8" ontology_id="DOID_162" text="cancer" type="disease"/>
    <entity charOffset="987-991" id="e38a8320180661475487156ee68de426868e6c45.c1.e9" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e0" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p0" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e1" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p1" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e2" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p2" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e3" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p3" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e4" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p4" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e5" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p5" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e6" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p6" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e7" e2="e38a8320180661475487156ee68de426868e6c45.c1.e8" id="e38a8320180661475487156ee68de426868e6c45.c1.p7" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c1.e8" e2="e38a8320180661475487156ee68de426868e6c45.c1.e9" id="e38a8320180661475487156ee68de426868e6c45.c1.p8" relation="true"/>
  </chunk>
  <chunk id="e38a8320180661475487156ee68de426868e6c45.c2" text="Cancers 2019, 11, 27 2 of 28 (SERCA), the mitochondrial Ca 2+ uniporter (MCU) and the Secretory Pathway Ca 2+ -ATPase (SPCA), which sequesters Ca 2+ into the Golgi lumen [1] [2] [3] [4]. An increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ) is produced by the opening of Ca 2+ -permeable channels, which are located either on the PM or on the membrane of endogenous organelles, in response to extracellular stimulation. Typically, extracellular agonists, including growth factors, cytokines, neurotransmitters and hormones, bind to their specific tyrosine kinase receptors (TKRs) or G q -protein coupled receptors (GPCRs), thereby recruiting, respectively, phospholipase Cγ (PLCγ) and PLCβ, which in turn cleave phosphatidylinositol-4,5-bisphosphate (PIP 2 ) into inositol-1,4,5-trisphosphate (InsP 3 ) and diacyl-glycerol (DAG) [1]. Subsequently, InsP 3 primes immobile InsP 3 receptors (InsP 3 Rs), which reside at juxtaposed endoplasmic reticulum (ER)-PM junctions, to respond to cytosolic Ca 2+ according to the process of Ca 2+ -induced Ca 2+ release (CICR), which enables to spatially restricted Ca 2+ signals to spread across the cytoplasm as a regenerative Ca 2+ wave [5, 6] . Moreover, InsP 3 -induced Ca 2+ release can be further amplified by the recruitment of adjoining ryanodine receptors (RyRs), which are also sensitive to CICR [7] . Additionally, InsP 3 -induced Ca 2+ release causes a large drop in the ER Ca 2+ concentration ([Ca 2+ ] ER ) which triggers a signaling cascade leading to the opening of a Ca 2+ -permeable pathway on the PM, known as store-operated Ca 2+ entry (SOCE) [8, 9] . SOCE is activated when ER Ca 2+ dissociates from the luminal EF hands domain of STIM1 (Stromal Interaction Molecule 1), the sensor of [Ca 2+ ] ER , which undergoes a dramatic conformational change and sub-cellular repositioning. The depletion of ER Ca 2+ induces STIM1 to oligomerize and translocate from its reticular location in the bulk ER to specialized ER-PM junctions (≈20 nm) where it forms STIM1 puncta and interacts with the pore-forming subunit of store-operated channels (SOCs), Orai1 [8] . The dynamic interplay between InsP 3 -induced ER Ca 2+ release and SOCE gives raise to distinct spatio-temporally complex Ca 2+ signatures, ranging from local Ca 2+ puffs to repetitive global Ca 2+ oscillations, that selectively regulate different cellular functions [2, 10, 11] .">
    <entity charOffset="96-103" id="e38a8320180661475487156ee68de426868e6c45.c2.e0" ontology_id="CHEBI_34922" text="Pathway" type="chemical"/>
    <entity charOffset="501-518" id="e38a8320180661475487156ee68de426868e6c45.c2.e1" ontology_id="CHEBI_25512" text="neurotransmitters" type="chemical"/>
    <entity charOffset="556-564" id="e38a8320180661475487156ee68de426868e6c45.c2.e2" ontology_id="CHEBI_17895" text="tyrosine" type="chemical"/>
    <entity charOffset="556-564" id="e38a8320180661475487156ee68de426868e6c45.c2.e3" ontology_id="CHEBI_18186" text="tyrosine" type="chemical"/>
    <entity charOffset="721-758" id="e38a8320180661475487156ee68de426868e6c45.c2.e4" ontology_id="CHEBI_18348" text="phosphatidylinositol-4,5-bisphosphate" type="chemical"/>
    <entity charOffset="760-763" id="e38a8320180661475487156ee68de426868e6c45.c2.e5" ontology_id="CHEBI_16500" text="PIP" type="chemical"/>
    <entity charOffset="1291-1300" id="e38a8320180661475487156ee68de426868e6c45.c2.e6" ontology_id="CHEBI_8925" text="ryanodine" type="chemical"/>
    <entity charOffset="1547-1554" id="e38a8320180661475487156ee68de426868e6c45.c2.e7" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="1671-1678" id="e38a8320180661475487156ee68de426868e6c45.c2.e8" ontology_id="CHEBI_8069" text="luminal" type="chemical"/>
    <entity charOffset="1725-1733" id="e38a8320180661475487156ee68de426868e6c45.c2.e9" ontology_id="CHEBI_25367" text="Molecule" type="chemical"/>
  </chunk>
  <chunk id="e38a8320180661475487156ee68de426868e6c45.c3" text="The ER is by far the largest and best studied intracellular Ca 2+ reservoir engaged by extracellular stimuli, possessing a complete repertoire of Ca 2+ pumps, i.e., SERCA, to effect filling, luminal Ca 2+ -binding proteins, e.g., calnexin and calreticulin, to effect buffering and Ca 2+ -permeable channels, i.e., InsP 3 Rs and RyRs, to effect release [7, 12] . Nevertheless, the ER is not the sole endogenous Ca 2+ store in mammalian cells. It has been shown that also the acidic vesicles of the endo-lysosomal (EL) system serve as an additional Ca 2+ reservoir that is recruited by extracellular ligands through the generation of the novel Ca 2+ -releasing second messenger, nicotinic acid adenine dinucleotide phosphate (NAADP) [12] [13] [14] [15] . The battery of Ca 2+ refilling and release mechanisms endowed to acidic EL vesicles is emerging as a crucial signalling network to finely tune local processes, such as membrane fusion and individualized vesicular movements [16] . In addition, the establishment of EL-ER membrane contact sites (MCSs) enables EL Ca 2+ release to trigger cytosolic Ca 2+ waves by recruiting ER-resident InsP 3 Rs and RyRs through the CICR process [17, 18] .">
    <entity charOffset="191-198" id="e38a8320180661475487156ee68de426868e6c45.c3.e0" ontology_id="CHEBI_8069" text="luminal" type="chemical"/>
    <entity charOffset="598-605" id="e38a8320180661475487156ee68de426868e6c45.c3.e1" ontology_id="CHEBI_52214" text="ligands" type="chemical"/>
    <entity charOffset="677-691" id="e38a8320180661475487156ee68de426868e6c45.c3.e2" ontology_id="CHEBI_15940" text="nicotinic acid" type="chemical"/>
    <entity charOffset="687-691" id="e38a8320180661475487156ee68de426868e6c45.c3.e3" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="692-699" id="e38a8320180661475487156ee68de426868e6c45.c3.e4" ontology_id="CHEBI_16708" text="adenine" type="chemical"/>
    <entity charOffset="700-712" id="e38a8320180661475487156ee68de426868e6c45.c3.e5" ontology_id="CHEBI_47885" text="dinucleotide" type="chemical"/>
    <entity charOffset="713-722" id="e38a8320180661475487156ee68de426868e6c45.c3.e6" ontology_id="CHEBI_18367" text="phosphate" type="chemical"/>
    <entity charOffset="724-729" id="e38a8320180661475487156ee68de426868e6c45.c3.e7" ontology_id="CHEBI_76072" text="NAADP" type="chemical"/>
  </chunk>
  <chunk id="e38a8320180661475487156ee68de426868e6c45.c4" text="Herein, we discuss the emerging role of EL Ca 2+ signalling in tumorigenesis [19] [20] [21] . We first illustrate the basic mechanisms of EL Ca 2+ refilling and release by focusing on the wealth of Ca 2+ -permeable channels that effect EL Ca 2+ mobilization, i.e., Transient Receptor Potential (TRP) Mucolipin 1-3 (TRPML1-3), two-pore channels 1-2 (TPC1-2), TRP Melastatin 2 (TRPM2), TRP Ankyrin 1 (TRPA1), P2X4 receptors and voltage-gated Ca 2+ channels ( Figure 1 ). Then, we describe how TPCs control several cancer hallmarks, including migration, invasiveness and angiogenesis, and the potential tumorigenic function of TRPML1. Finally, we speculate about the possibility to interfere with the EL Ca 2+ signalling machinery to design alternative anticancer treatments, by focusing on TPCs as emerging molecular targets.">
    <entity charOffset="32-36" id="e38a8320180661475487156ee68de426868e6c45.c4.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="295-298" id="e38a8320180661475487156ee68de426868e6c45.c4.e1" ontology_id="CHEBI_16828" text="TRP" type="chemical"/>
    <entity charOffset="295-298" id="e38a8320180661475487156ee68de426868e6c45.c4.e2" ontology_id="CHEBI_27897" text="TRP" type="chemical"/>
    <entity charOffset="358-361" id="e38a8320180661475487156ee68de426868e6c45.c4.e3" ontology_id="CHEBI_16828" text="TRP" type="chemical"/>
    <entity charOffset="358-361" id="e38a8320180661475487156ee68de426868e6c45.c4.e4" ontology_id="CHEBI_27897" text="TRP" type="chemical"/>
    <entity charOffset="384-387" id="e38a8320180661475487156ee68de426868e6c45.c4.e5" ontology_id="CHEBI_16828" text="TRP" type="chemical"/>
    <entity charOffset="384-387" id="e38a8320180661475487156ee68de426868e6c45.c4.e6" ontology_id="CHEBI_27897" text="TRP" type="chemical"/>
    <entity charOffset="512-518" id="e38a8320180661475487156ee68de426868e6c45.c4.e7" ontology_id="DOID_162" text="cancer" type="disease"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e0" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p0" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e1" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p1" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e2" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p2" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e3" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p3" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e4" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p4" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e5" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p5" relation="true"/>
    <pair e1="e38a8320180661475487156ee68de426868e6c45.c4.e6" e2="e38a8320180661475487156ee68de426868e6c45.c4.e7" id="e38a8320180661475487156ee68de426868e6c45.c4.p6" relation="true"/>
  </chunk>
</document>
